145 related articles for article (PubMed ID: 4114343)
1. [Clinical studies of the oral and parenteral action of k-strophanthin-alpha in decompensated heart patients].
Krämer KD; Ghabussi P; Hochrein H
Dtsch Med Wochenschr; 1972 Jun; 97(22):870-7. PubMed ID: 4114343
[No Abstract] [Full Text] [Related]
2. [Clinical study of the action of a preparation of K-strophanthin for intramuscular use].
Colombo L; Monarca A; Zanetta R
Minerva Cardioangiol; 1978 Sep; 26(9):609-14. PubMed ID: 703962
[No Abstract] [Full Text] [Related]
3. [Effect of cardiac glycosides on the duration of systole. A comparison between proscillaridin and strophanthin].
Heierli C; Schweizer W; Burkart F
Schweiz Med Wochenschr; 1971 May; 101(18):638-42. PubMed ID: 5103642
[No Abstract] [Full Text] [Related]
4. [Tolerance increase of k-strophantin-alpha through d,l-alpha-tocopherol acetate. Clinical studies in patients with decompensated heart diseases].
Ghabussi P; Krämer KD; Hochrein H
Arzneimittelforschung; 1974 Feb; 24(2):202-5. PubMed ID: 4406371
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of the combination of strophanthin and ATP in the therapy of chronic circulatory insufficiency].
Karbasnikova GN
Sov Med; 1974 Aug; 0(8):90-4. PubMed ID: 4428283
[No Abstract] [Full Text] [Related]
6. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)].
Fan-Tkhi-Ngok-Shiong
Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844
[No Abstract] [Full Text] [Related]
7. [Plasma levels and urinary elimination of k-strophanthoside in venous and muscular administration in cardiac disease patients].
Marzo A; Ghirardi P; Scalvini A; Delmonte A; Ferrari Bravo A; Goldstein Balocan M; Marchetti G
Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1589-93. PubMed ID: 4458744
[No Abstract] [Full Text] [Related]
8. [On the quantitative effectiveness of k-strophanthin-alpha (Cymarin) in intravenous and oral administration].
Storz H
Dtsch Med Wochenschr; 1969 May; 94(22):1166-9. PubMed ID: 5768542
[No Abstract] [Full Text] [Related]
9. [Epicritical views on the long-term management of cardiac insufficiency using Cyma in (Alvonal MR)].
Russy W
Landarzt; 1967 Nov; 43(33):1634-6. PubMed ID: 5594634
[No Abstract] [Full Text] [Related]
10. [On strophanthin therapy. Advantages and disadvantages].
Effert S; Meyer J
Dtsch Med Wochenschr; 1967 Sep; 92(36):1637-9. PubMed ID: 6051288
[No Abstract] [Full Text] [Related]
11. [Contribution to oral strophanthin therapy].
Lampe K
Med Welt; 1968 Jun; 26():1569-72. PubMed ID: 5718813
[No Abstract] [Full Text] [Related]
12. [Comparative hemodynamic studies on various heart glycosides].
Gotsch K; Klein WW; Leb G; Pavek P; Passath A
Z Kreislaufforsch; 1972 Jul; 61(7):577-87. PubMed ID: 5055577
[No Abstract] [Full Text] [Related]
13. [Contribution on oral strophanthin therapy].
Stienen H
Med Welt; 1969 Jul; 27():1540-1. PubMed ID: 5799793
[No Abstract] [Full Text] [Related]
14. [Comparative clinical studies of scillaglycoside A and k-strophanthin].
Nusser E; Eberl R
Med Welt; 1968 Feb; 9():454-7. PubMed ID: 5753203
[No Abstract] [Full Text] [Related]
15. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
Apanasenko AA
Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
[No Abstract] [Full Text] [Related]
16. [Principles and directives for practical treatment with cardiac glycosides].
Dörffel EF
Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
[No Abstract] [Full Text] [Related]
17. [Bathmotropic effect of panangin and strophanthin in patients with extrasystole].
Ianushkevichus ZI; Zabela PV
Kardiologiia; 1976 Dec; 16(12):81-7. PubMed ID: 64640
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
Hansel J
Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
[No Abstract] [Full Text] [Related]
19. [Combined use of glucagon and strophanthin in myocardial infarct complicated by severe cardiac insufficiency].
Riabinin VA; Golikov AP
Kardiologiia; 1978 Jan; 18(1):62-8. PubMed ID: 342797
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of cardiac insufficiency using alpha-acetyldigitoxin].
Lander E; Krohn E; Kramer P
Fortschr Med; 1973 Nov; 91(33):1329-30. PubMed ID: 4765769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
